“This is the first and largest population-based cross-sectional study of hospitalized patients to explore the association between cannabis use and HCC,” authors concluded.
“By failing to take up the case, SCOTUS … continues to evade the fundamental question with regard to cannabis’ medical validity.”
“The U.S. has a plethora of consumer protection laws. … So, it is understandable that Americans expect these same consumer protections in cannabis,” said the President & Founder of FOCUS.
Investigators concluded, “There is an urgent need to implement well-designed studies to evaluate the effectiveness and safety of medical marijuana for treating adults with migraines.”
“These data are consistent with other surveys showing that marijuana regulation policies can be implemented in a manner that provides access for adults while simultaneously limiting youth access and misuse.”